Harvard, Yale and 11 other Universities or clinics
Post# of 151809

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) and for Mild to Moderate COVID-19
https://clinicaltrials.gov/ct2/show/NCT043472...amp;rank=2
https://clinicaltrials.gov/ct2/results?cond=C...&dist=
That is huge!

